NCT06020365View on ClinicalTrials.gov

Investigation of Fecal Microbiota Transplant in Chronic Intestinal Pseudo-obstruction Patients

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

August 1, 2023

Study Completion Date

August 1, 2023

Conditions
Intestinal Pseudo-ObstructionFecal Microbiota Transplantation
Interventions
OTHER

sequential fecal microbiota transplant combined with small intestinal fluid transplant

for eligible patients, the investigator use rifaximin, three times daily, 0.4 g each time, lasting 6 days followed by fecal microbiota transplant combined with small intestinal fluid transplant for 6 days. These procedures were repeated every 28 days.

Trial Locations (1)

Unknown

Shanghai Tenth People's Hospital, Shanghai

All Listed Sponsors
lead

Shanghai 10th People's Hospital

OTHER

NCT06020365 - Investigation of Fecal Microbiota Transplant in Chronic Intestinal Pseudo-obstruction Patients | Biotech Hunter | Biotech Hunter